5-(2-苯基-1,2,3-三唑基)-3-芳基吡唑啉衍生物的合成及其荧光性能

以2-苯基-1, 2, 3-三唑基-4-甲醛为原料, 与苯乙酮［或取代苯乙酮(1a~1d)］发生羟醛缩合, 生成相应的查尔酮(2a~2d), 再与不同的肼反应, 合成了12种新的5位含2-苯基-1, 2, 3-三唑基的吡唑啉衍生物3a~3d, 4a~4d, 5a~5d. 化合物的结构经元素分析、 IR光谱和1 H NMR谱确认, 并测定了化合物的荧光光谱. 结果显示所合成的目标化合物有荧光, 是一类新型的荧光化合物.     

新型含吡唑基1,2,4-三唑衍生物的合成

以1-苯基-3-甲基-5-吡唑啉酮为起始原料,经氯甲酰化、氧化、酯化、肼解、成盐及闭环反应制得4-氨基-5-(1-苯基-3-甲基-5-氯吡唑)-1,2,4-三唑-3-硫酮(6);6与苯甲醛经缩合反应制得4-苯甲亚胺基-5-(5-氯-3-甲基-1-苯基)吡唑-4H-1,2,4-三唑-3-硫酮(7);7与对硝基苄氯反应合成了2个新型含吡唑基1,2,4-三唑化合物,其结构经1H NMR,IR和元素分析表征。     

1-苯基-3-(3'-吲哚基)-5-取代苯基-2-吡唑啉的合成及1H NMR和MS中的取代基效应

J-(3'-吲哚基)-3-取代苯基-2-丙烯-1-酮与茉肼反应,合成了10种新的1-苯基-3-(3'-吲哚基)-5-取代苯基-2-吡唑啉衍生物,其结构通过各种波谱证实.讨论了此系列化合物¹HNMR和Ms中的取代基效应,得出取代基常数σ或σ⁺与质子化学位移,碎片相对丰度之间存在着良好的线性关系.     

1-(2-苯并噻唑基)-5-(2-苯基-1,2,3-三唑基)-3-芳基-2-吡唑啉衍生物的合成及其荧光性能

以2-苯基-1,2,3-三唑基-4-甲醛为原料,与苯乙酮或取代苯乙酮发生羟醛缩合生成相应的查尔酮；再与2-肼基苯并噻唑反应,合成了5个含1,2,3-三唑基、苯并噻唑基的新型吡唑啉衍生物，其结构经¹H NMR、 IR和元素分析表征。荧光性能研究结果表明：该类化合物具有良好的荧光性,其最大发射波长在427～444 nm,荧光强度大小与衍生物中不同的取代基有关     

新型吡唑啉酮衍生物的固相合成

以2-苯基-1,2,3-三唑-4-甲醛和3-甲基-1-苯基-5-吡唑啉酮为原料,采用微波辐射固相合成法,经Knoeve-nagel缩合反应制得3-甲基-1-苯基4-(2-苯基-1,2,3-三唑4-亚甲基)-5-吡唑啉酮(2);2与吲哚发生Michael加成反应合成了吡唑啉酮衍生物,其结构经1H NMR和IR确证.     

含吡唑1,2,4-三唑噻二嗪衍生物的合成及抑菌活性

1-苯基-3-甲基-5-氯-4-吡唑甲醛与4-氨基-5-取代苯基-1,2,4-三唑-3-硫酮缩合生成4-(1-苯基-3-甲基-5-氯吡唑次甲亚胺基)-5-(取代苯基)-2H-1,2,4-三唑-3(4H)-硫酮,再烷基加成化为新型含吡唑基5,6-2H-1,2,4-三唑[3,4-b][1,3,4]噻二嗪衍生物。 化合物结构经¹H NMR、IR以及元素分析确认。 初步生物活性测试结果表明,在100 mg/L浓度下,化合物8a(3-(2-甲基苯基)-6-(5-氯-2-甲基-4-苯基吡唑)-7-(4-硝基苯基)-5H-1,2,4-三唑[3,4-b][1,3,4]噻二嗪)对黄瓜炭疽病的抑制率达90%。     

取代吡唑啉睡物的合成与生物活性

采用α－三唑－β－烷氧基芳酮与肼关环，备了１，３－二苯基－４－三唑基吡唑啉１ａ，１－苯基－３－对氯苯基－４－三唑基吡唑啉１ｂｔ ３－ｂｃ ｗａ ａｓｇ ａｄ －４－ｄｇ ｋｗｗ ａｄ ｋｘｘ ｋｗｗ ｋｓｓ （７）     

1-(2-羟基苯甲酰基)-3-甲基-4-取代苯腙基-吡唑啉酮及其中间体的合成、表征及抑菌活性

依据生物活性叠加原理,将邻羟苯基、吡唑啉酮、苯腙基团进行合理组合,构建并合成了2-取代苯腙基-3-(2-羟基苯甲酰腙基)-丁酸乙酯(3a～3f)和1-(2-羟基苯甲酰基)-3-甲基-4-取代苯腙基-吡唑啉酮(4a～4f)两类、共计12种化合物,其中8种化合物未见报道,12种化合物的抑菌活性均未见报道.以芳胺为原料,经重氮化、与乙酰乙酸乙酯反应,与水杨酰肼缩合制得3a～3f,3a～3f经分子内关环制得4a～4f,化合物的结构经IR,1HNMR,元素分析等证实.生物活性测试表明,质量浓度为0.01%时,化合物3b,3c对大肠杆菌的抑菌率高达100%,具有很强的抑菌活性;化合物3a～3f对白色念珠菌、金黄色葡萄球菌的抑菌率均达70%以上,具有较强的抑菌活性;化合物4a～4f对白色念珠菌、大肠杆菌的抑菌率均接近或达到100%,具有很强的抑菌活性,对金黄色葡萄球菌的抑菌率均达78%以上,具有较强抑菌活性;与3a～3f相比,形成吡唑啉酮环后的化合物4a～4f的抗菌活性更高.     

3-取代胺甲基-5-连三唑基-1, 3, 4-恶二唑-2-硫酮的合成

2-苯基-1,2,3-三唑-4-甲酰肼(1)在CS~2/KOH作用下环化得到5-(2-苯基-1,2,3-连三唑-4-基)-1,3,4-恶二唑-2-硫酮(2),2经Mannich反应合成得到标题化合物3-(取代胺甲基-5-(2-苯基-1,2,3-连三唑-4-基)-1,3,4-恶二唑-2-硫酮(3)。     

含三唑啉硫酮槟榔碱衍生物的合成和生物活性

烟酸经酯化、肼解、与取代芳酸异硫氰酸酯缩合成 1 (3 吡啶甲酰基 ) 4 芳基氨基硫脲 (2 ) ,2经环合生成 2 (3 吡啶 ) 4 芳基 1,3,4 三唑啉 5 硫酮 (3) ,接着用碘甲烷对吡啶环季铵化得相应的季铵盐 4 ,4用硼氢化钠还原可得目标物 2 (1 甲基 1,2 ,5 ,6 四氢吡啶 3 基 ) 4 芳基 1,2 ,4 三唑啉 5 硫酮 (5 ) .对所合成的目标化合物进行了舒张血管活性实验     

Synthesis and antibacterial activity of a new series of 2,3,5,7-substituted-pyrido[2,3-d]pyrimidin-4(3h)-one derivatives

A new series of 2,3,5,7-substituted-pyrido[2,3-d]pyrimidin-4(3H)-one derivatives were prepared from 2-amino-N,6-substituted phenyl-4-(trifluoromethyl or methyl)nicotinamides. The key intermediate 2-amino-N,6-substituted phenyl-4-(trifluoromethyl or methyl)nicotinamides were synthesized from 2-bromo-N,6-disubstituted phenyl-4-(trifluoromethyl or methyl)nicotinamides as well as from ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) coupling of 2-amino-4,6-substituted nicotinic acid and substituted arylamines. All the synthesized compounds were screened for antibacterial activity against Gram +ve and Gram -ve bacteria. Compound 7c showed better antibacterial activity against Gram +ve and Gram -ve bacteria.     

3-取代卓酚酮5位偶联产物的溴氧化成环反应

报道了采用溴氧化3-异丙烯基卓酚酮和3-肉桂酰基卓酚酮合成杂环并卓酮化合物的新方法。3-异丙烯基卓酚酮5位偶联产物1a-1f和3-肉桂酰基卓酚酮5位偶联产物3a-3d分别在吡啶介质中与过量溴作用生成5-取代苯偶氮基-7-溴-3-甲基-8-氢环庚并呋喃-8-酮2a-2f和6-取代苯偶氮基-2-苯基-8-溴-4,9-二氢环庚并吡喃-4,9-二酮4a-4d。     

当归多糖ASP3及其水解产物的NMR光谱分析

对当归多糖ASP3的糖链结构进行分析. 分别采用0.2 mol/L三氟乙酸(Trifluoroacetic acid, TFA)和内切-α-(1→4)-聚半乳糖醛酸酶(EndoPG)对ASP3进行部分酸水解和酶水解, 并对水解前后多糖组分的1D和2D NMR光谱特征进行分析. 实验结果表明, ASP3是一种果胶多糖. GalpA和Rhap位于多糖分子的主链, 由1→4-D-GalpA相连形成的“光滑区”(半乳糖醛酸聚糖)是其主要组成部分; 由α-(1→4)-GalpA通过O4位与α-(1→2)-和α-(1→2,4)-Rhap的O2位交替连接所形成的重复单元[→4)-α-GalpA-(1→2)-α-Rhap-(1→]构成具有较高分支的“毛发区”(富含中性糖侧链的鼠李半乳糖醛酸聚糖). Galp和Araf是中性糖侧链的主要组成, 通过Rhap残基的O4位与主链相连. 非还原性末端T-β-Galp, β-(1→3)-, β-(1→3,6)-, β-(1→4)-, β-(1→4,6)-Galp聚合形成以β-(1→3,6)-Galp为分支点的β-(1→6)-半乳聚糖和以β-(1→4,6)-Galp为分支点的β-(1→4)-半乳聚糖. T-α-Araf, α-(1→5)-Araf和α-(1→3,5)-Araf聚合形成以α-(1→3,5)-Araf为分支点的α-(1→5)-阿拉伯聚糖. 此外, 由α-(1→5)-阿拉伯聚糖通过α-(1→3)连接与β-(1→6)-半乳聚糖末端聚合形成阿拉伯半乳聚糖.     

Synthesis and biological evaluation of some novel-3-(5-substituted benzimidazol-2-yl)-5-arylisoxazolines

<正>The synthesis of a new series of 3-(5-substituted benzimidazol-2-yl)-5-arylisoxazolines(6a-h) was achieved in excellent yields by the condensation of 1-(1H-benzimidazol-2-yl)-3-(substituted phenyl)prop-2-en-1-ones(5a-h) with hydroxylamine at room temperature.These 1-(1H-benzimidazol-2-yl)-3-(substituted phenyl)prop-2-en-1-ones(5a-h) were obtained by the condensation of 2-acetyl benzimidazoles(4a-d) with different aromatic aldehydes,which in turn were obtained by the oxidation of 2-(α-hydroxy) ethyl benzimidazoles(3a-d) prepared by the reaction of o-phenylenediamines(1a-d) withα-hydroxy propionic acid 2. The synthesized compounds were characterized by their IR,~1H NMR and MS analyses.These compounds were screened for their antibacterial and antifungal activity by standard methods and found some of them active.     

Synthesis, spectral characterization and biological activity of zinc(II) complexes with 3-substituted phenyl-4-amino-5-hydrazino-1, 2, 4-triazole Schiff bases

New Zn(II) complexes have been synthesized by the reactions of zinc(II) acetate with Schiff bases derived from 3-substituted phenyl-4-amino-5-hydrazino-1, 2, 4-triazole and benzaldehyde, 2-hydroxyacetophenone or indoline-2,3-dione. All these complexes are soluble in DMF and DMSO; low molar conductance values indicate that they are non-electrolytes. Elemental analyses suggest that the complexes have 1:1 stoichiometry of the type [ZnL(H(2)O)(2)], [ZnL'(OAc)(2)(H(2)O)(2)] (L=dianionic Schiff bases derived from 3-(substituted phenyl)-4-amino-5-hydrazino-1, 2, 4-triazole and 2-hydroxyacetophenone or indoline-2,3-dione; L'=neutral Schiff bases derived from 3-(substituted phenyl)-4-amino-5-hydrazino-1, 2, 4-triazole and benzaldehyde) and they were characterized by FT-IR, (1)H NMR, (13)C NMR and FAB mass. All these Schiff bases and their complexes have also been screened for their antibacterial activities against Bacillus subtilis, Escherichia coli and antifungal activities against Colletotrichum falcatum, Aspergillus niger, Fusarium oxysporium and Carvularia pallescence by petriplates methods.     

新型1,2,3-三唑类化合物的合成及抗菌构效关系

根据活性基团拼接原理, 以4-取代-苯胺为原料, 经重氮化、 关环和缩合反应合成了17个化合物1-(4-取代苯基)-5-取代苯基亚氨基-4-取代-1,2,3-三唑(7a~7c和13a~13d)和1-(4-取代苯基)-5-取代苄基氨基-4-取代-1,2,3-三唑(5a~5c, 10a~10c和14a~14d), 其中化合物5a~5c, 7b, 7c, 10a, 10c, 13b~13d和14b~14c为新化合物, 对所制备化合物的结构进行了表征. 生物活性测试结果表明, 所有化合物均表现出一定的抑菌活性, 对大肠杆菌的抑菌活性均优于氟康唑; 化合物7a和10c对金黄色葡萄球菌的抑制活性明显优于氟康唑; 而化合物13a和13d则对白色念球菌表现出良好的抑制活性, 与三氯生相当.     

Synthesis of Azo-Sulfa Drugs Based on 2-Pyridinone and 2-Pyridinethione

Some new azo sulfa drugs 3-cyano-4,6-diphenyl-1-[4-(N-substituted)sulfamyl]phenylazo-2-pyridinone dyes (1-6) and 3-cyano-4,6-diphenyl-1-[4-(N-substituted)sulfamyl]phenylazo-2-pyridinethione dyes (1′-6′) were synthesized by coupling of 4-(N-substituted)sulfamylbenzene diazonium salts with 3-cyano-4,6-diphenyl-2-pyridinone and/or with 3-cyano-4,6-diphenyl-2-pyridin-ethione. The corresponding iron (1a-6a, 1′a-6′a), copper (1b-6b, 1′b-6′b) and mercury (1c-6c, 1′c-6′c) chelates wvere also prepared. All synthesized compounds were screened in vitro for antibacterial and antifungal activities.     

Synthesis, IR spectral studies and quantum-chemical calculations on 1,2-dihydronaphto[1,2-e]oxazine-3-thiones and 3,4-dihydrobenzo[e][1,3]oxazine-2-thione

2-Hydroxy-1-naphthaldehyde (1) was reacted with substituted anilines to afford 1-(substituted phenyliminomethyl)naphthalen)-2-ols (2). The reduction of these imines by NaBH₄ gave 1-((substituted phenylaminomethyl)naphthalen)-2-ols (3) which were cyclized with thiophosgene to give corresponding 2-substituted phenyl-1,2-dihydronaphto[1,2-e]oxazine-3-thiones (4). 3-p-Tolyl-3,4-dihydrobenzo[e][1,3]oxazine-2-thione (8) was also obtained by the same way. The structures of these new compounds were determined by ¹H NMR, IR spectroscopic data and elemental analyses. AM1, PM3 and ab initio (at Hartree–Fock level with 3-21G basis set) methods were used to study the molecular geometry of the compounds. A complete infrared spectral analysis of the oxazines has been performed in this paper. Observed frequencies of the molecules were compared with calculated normal mode analysis which was carried out on the basis of RHF/3-21G method. Assignments of vibrational bands (in the range of 1760–400 cm⁻¹) have been performed by taking into account the results of the ab initio vibrational analysis. The mechanism of the cyclization reaction between (3a) and thiophosgene was studied by the semi-empirical AM1 and ab initio (RHF) calculations.     

S-烃基-1-烃基-3-[4-(苯并咪唑-2-巯基)苯基]异硫脲的合成及其iNOS抑制活性

以2-巯基苯并咪唑(1)为原料,经缩合和还原得到2-(4-氨基苯硫基)苯并咪唑(3),再与异硫氰酸苯甲酰酯或异硫氰酸烃基酯反应得到取代硫脲(5和7),最后与卤代烃反应得到20个新的S-烃基-1-烃基-3-[4-(苯并咪唑-2-巯基)苯基]异硫脲化合物(6和8),其结构经IR,¹HNMR,MS及元素分析确证.初步的药理试验表明,20个目标化合物均有不同程度的iNOS抑制活性,其中化合物6b,8d和8f的iNOS抑制活性与阳性对照药氨基胍相当.